AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 99,274 Value ($000) $1,199 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 98,657 Value ($000) $1,341 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 100,576 Value ($000) $645 Avg Close $4.86 Range $3.11 - $6.70
Q2 2024
Shares 28,779 Value ($000) $55 Avg Close $1.94 Range $1.57 - $2.89
Q1 2024
Shares 69,403 Value ($000) $197 Avg Close $13.08 Range $2.67 - $19.95
Q4 2023
Shares 68,283 Value ($000) $1,005 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 68,960 Value ($000) $1,263 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 68,095 Value ($000) $1,469 Avg Close $27.01 Range $20.79 - $31.77
Q1 2023
Shares 75,962 Value ($000) $2 Avg Close $34.74 Range $26.64 - $41.93
Q4 2022
Shares 71,564 Value ($000) $3 Avg Close $35.49 Range $28.13 - $39.77
Q3 2022
Shares 45,793 Value ($000) $1,289 Avg Close $24.95 Range $15.80 - $32.80
Q2 2022
Shares 16,174 Value ($000) $312 Avg Close $11.87 Range $6.51 - $20.74